DCF — ORLANDO HEALTH
Enterprise Value: $-2.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.1B
Enterprise Value
$-703.6M
PV of Cash Flows
$-1.4B
PV of Terminal Value
$-2.3B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.4B | $-110.2M | -5.0% | $-213.9M | $-194.5M |
| Year 2 | $2.5B | $-88.3M | -4.0% | $-195.1M | $-161.3M |
| Year 3 | $2.6B | $-65.0M | -3.0% | $-175.0M | $-131.5M |
| Year 4 | $2.7B | $-53.5M | -2.0% | $-166.9M | $-114.0M |
| Year 5 | $2.8B | $-48.3M | -2.0% | $-165.0M | $-102.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000006306747
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5